| Non-Hodgkin Lymphoma investigated in trials for …INVESTIGATED_IN_TRIALSderived200 of 300show all (up to 200) |
|---|
| → investigated in trials for | Dexamethasonesmall molecule 828 trials (260 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 828 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Rituximabmonoclonal_antibody 633 trials (194 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 633 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cyclophosphamidesmall molecule 598 trials (188 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 598 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lenalidomidesmall molecule 570 trials (202 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 570 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bortezomibsmall molecule 471 trials (101 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 471 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fludarabinesmall molecule 330 trials (90 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 330 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalansmall_molecule 228 trials (32 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 228 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daratumumabmonoclonal antibody 224 trials (121 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 224 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pomalidomidesmall molecule 201 trials (86 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 201 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vincristinesmall_molecule 198 trials (71 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 198 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Doxorubicinsmall_molecule 189 trials (68 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 189 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisonesmall molecule 189 trials (71 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 189 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carfilzomibother 180 trials (67 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 180 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Etoposidesmall molecule 178 trials (45 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 178 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibrutinibsmall molecule 166 trials (61 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 166 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Venetoclaxsmall molecule 165 trials (84 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 165 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bendamustinesmall_molecule 150 trials (45 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 150 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Obinutuzumabmonoclonal antibody 138 trials (78 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 138 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Methotrexatesmall_molecule 127 trials (39 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 127 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cytarabinesmall molecule 114 trials (35 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 114 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thalidomidesmall molecule 94 trials (6 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 94 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Filgrastimother 92 trials (7 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 92 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ixazomibsmall molecule 86 trials (16 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 86 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pembrolizumabmonoclonal antibody 83 trials (27 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 83 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Gemcitabinesmall molecule 73 trials (15 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 73 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Busulfansmall molecule 71 trials (11 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 71 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zanubrutinibsmall_molecule 71 trials (53 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 71 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Acalabrutinibsmall molecule 64 trials (48 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 64 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nivolumabmonoclonal antibody 63 trials (16 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 63 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belantamab Mafodotinadc 62 trials (40 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 62 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elotuzumabmonoclonal antibody 58 trials (18 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Isatuximabmonoclonal antibody 58 trials (44 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 58 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selinexorsmall molecule 54 trials (25 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 54 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brentuximab Vedotinadc 52 trials (12 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 52 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Teclistamabmonoclonal antibody 50 trials (46 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 50 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Elranatamabmonoclonal antibody 46 trials (37 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 46 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Panobinostatsmall molecule 43 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pirtobrutinibsmall molecule 43 trials (37 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Romidepsinother 43 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 43 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Plerixaforsmall_molecule 42 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 42 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Azacitidinesmall molecule 41 trials (16 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carmustinesmall_molecule 41 trials (5 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 41 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epcoritamabmonoclonal antibody 40 trials (37 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 40 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ofatumumabmonoclonal antibody 39 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vorinostatsmall molecule 39 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 39 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alemtuzumabmonoclonal antibody 37 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ifosfamidesmall molecule 37 trials (12 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mosunetuzumabmonoclonal antibody 37 trials (33 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 37 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Carboplatinsmall molecule 36 trials (11 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cisplatinsmall molecule 36 trials (8 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sirolimussmall molecule 36 trials (6 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 36 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegaspargaseother 34 trials (11 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 34 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Glofitamabmonoclonal antibody 32 trials (25 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Talquetamabmonoclonal antibody 32 trials (27 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 32 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pegfilgrastimother 31 trials (8 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 31 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Duvelisibsmall molecule 30 trials (10 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 30 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idelalisibsmall_molecule 29 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Polatuzumab Vedotinadc 29 trials (20 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 29 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Copanlisibsmall molecule 28 trials (7 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 28 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thiotepasmall molecule 26 trials (9 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 26 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mercaptopurinesmall molecule 25 trials (11 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Oxaliplatinsmall molecule 25 trials (10 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 25 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mogamulizumabmonoclonal antibody 24 trials (8 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tafasitamabmonoclonal antibody 24 trials (18 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 24 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Leucovorinsmall molecule 23 trials (5 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pralatrexatesmall molecule 23 trials (8 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Prednisolonesmall molecule 23 trials (9 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tazemetostatsmall molecule 23 trials (10 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 23 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aldesleukinother 22 trials (4 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Clofarabinesmall molecule 22 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Zoledronic Acidsmall_molecule 22 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 22 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Lisocabtagene Maraleucelgene therapy 20 trials (11 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ruxolitinibsmall molecule 20 trials (13 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 20 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axicabtagene Ciloleucelgene therapy 19 trials (10 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dasatinibsmall molecule 19 trials (6 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 19 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Belinostatsmall molecule 18 trials (5 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Durvalumabmonoclonal antibody 18 trials (4 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Everolimussmall molecule 18 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ibritumomab Tiuxetanmonoclonal antibody 18 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 18 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chemotherapy 17 trials (4 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temsirolimussmall molecule 17 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 17 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Daunorubicinsmall molecule 16 trials (7 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Linvoseltamabmonoclonal antibody 16 trials (14 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 16 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Blinatumomabmonoclonal antibody 15 trials (8 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Crizotinibsmall molecule 15 trials (7 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Loncastuximab Tesirineadc 15 trials (9 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Thioguaninesmall molecule 15 trials (6 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 15 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Atezolizumabmonoclonal antibody 14 trials (5 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cladribinesmall molecule 14 trials (5 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ipilimumabmonoclonal antibody 14 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nelarabinesmall molecule 14 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 14 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idecabtagene Vicleucelgene therapy 13 trials (6 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mitoxantronesmall molecule 13 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Palbociclibsmall molecule 13 trials (5 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tisagenlecleucelcell therapy 13 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 13 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Asparaginaseother 12 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bevacizumabmonoclonal antibody 12 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Decitabinesmall molecule 12 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 12 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alisertibsmall molecule 11 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trametinibsmall molecule 11 trials (8 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 11 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nirogacestatsmall molecule 10 trials (8 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Odronextamabmonoclonal antibody 10 trials (9 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sunitinibsmall molecule 10 trials (4 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 10 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvocidibsmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Arsenic Trioxidesmall molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Inotuzumab Ozogamicinadc 9 trials (5 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Temozolomidesmall molecule 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vindesinesmall molecule 9 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vinorelbinesmall_molecule 9 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 9 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Aspirinsmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Avelumabmonoclonal antibody 8 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Calaspargase Pegolother 8 trials (7 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Chlorambucilsmall molecule 8 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ciltacabtagene Autoleucelgene therapy 8 trials (6 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sintilimabmonoclonal antibody 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tanespimycinsmall molecule 8 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tretinoinsmall molecule 8 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vemurafenibsmall molecule 8 trials (4 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 8 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abexinostatsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brexucabtagene Autoleucelgene therapy 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Camrelizumabmonoclonal antibody 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dinaciclibsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzastaurinsmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Nab-paclitaxel 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Paclitaxelsmall molecule 7 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pentostatinsmall molecule 7 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Perifosinesmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tipifarnibsmall molecule 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Tislelizumabmonoclonal antibody 7 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Topotecansmall molecule 7 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 7 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cemiplimabmonoclonal antibody 6 trials (5 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Denosumabmonoclonal antibody 6 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Mechlorethaminesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Melphalan Flufenamidesmall molecule 6 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Olaparibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Vismodegibsmall molecule 6 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 6 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Abemaciclibsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bexarotenesmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Binimetinibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Buparlisibsmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dabrafenibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erdafitinibsmall molecule 5 trials (4 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Irinotecansmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Metforminsmall molecule 5 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pacritinibsmall molecule 5 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenib Tosylatesmall molecule 5 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 5 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afatinibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bleomycin 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cabozantinibsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capecitabinesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dordavipronesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enzalutamidesmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Epirubicinsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Idarubicinsmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Imatinib Mesylatesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Larotrectinibsmall molecule 4 trials (4 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Navtemadlinsmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | O6-Benzylguaninesmall molecule 4 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pemetrexedsmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Procarbazinesmall molecule 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sapanisertibsmall molecule 4 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumabmonoclonal antibody 4 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Treosulfansmall molecule 4 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 4 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Akt Inhibitor MK2206 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Anti-PD1 Monoclonal Antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Bimiralisibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Celecoxibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | CHOP Regimen 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Cobimetinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Enasidenibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fluorouracilsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Galiximabmonoclonal antibody 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hematopoietic Cell Transplantation 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Hydroxychloroquinesmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Moxetumomab Pasudotoxadc 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Pixantronesmall_molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ponatinibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Radiation Therapy 3 trials (3 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Samotolisibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Selumetinibsmall molecule 3 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Sorafenibsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Taselisibsmall molecule 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Trastuzumab Emtansineadc 3 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Valproic Acidsmall molecule 3 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 3 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Adavosertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Afliberceptother 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alectinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Alvespimycinsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Apitolisibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Axitinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Brigatinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Capivasertibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ceritinibsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Docetaxelsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Dostarlimabmonoclonal antibody 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Encorafenibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Ensartinibsmall molecule 2 trials (2 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Erlotinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fexagratinibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |
| → investigated in trials for | Fulvestrantsmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants | — | — | Non-Hodgkin Lymphoma | 2 | Observed | clinicaltrials | graph → |